Al Abdali Hospital, Amman · Dr. Yaman Al Tall

Best Doctor for Prostate Cancer Treatment in Jordan

Prostate cancer is one of the most common cancers in men, and also one of the most manageable when caught early through routine screening. Dr. Yaman Al Tall, consultant urologist, handles evaluation and treatment — from active surveillance for low-risk cases, to surgical removal, up to coordinating radiation or hormone therapy when needed — with personal follow-up from him at every step.

Message Us on WhatsApp Now Call: 079 034 5019

Trusted coverage and documentation of Dr. Yaman Al Tall:

Rigicon Academy Jordan News Agency (Petra) Al Dustour newspaper Madar Al Saa

Most early-stage prostate cancer causes no symptoms at all. That’s why waiting for a specific sign isn’t the right approach — periodic screening (PSA testing and a digital exam) after a certain age is the actual way to catch it early, not symptoms.

Overview

What Is Prostate Cancer?

Prostate cancer originates from the cells of the prostate gland itself, and is entirely different from benign prostatic hyperplasia, which is common with aging — the two conditions are separate and neither turns into the other, though they can exist together in the same patient. Many cases of prostate cancer are slow-growing, while some are more aggressive and require faster intervention.

Evaluation usually starts with a PSA test and a digital exam, and when there’s cause for concern, a multiparametric MRI of the prostate is requested, and sometimes a precisely targeted biopsy to confirm the diagnosis and determine the tumor’s grade and potential aggressiveness.

Why This Deserves Attention Now

Four Reasons Regular Screening Is Worth Your Time

The Outcome

Far better outcomes with early detection

Cases confined to the prostate and caught through routine screening are often treated with excellent results.

Precision

MRI and targeted biopsy, not guesswork

Modern imaging precisely identifies areas of suspicion before any biopsy, so the sample is targeted rather than random.

Speed

From an elevated PSA result to a clear plan, quickly

No need for a long wait between a test and its interpretation — the pathway from screening to evaluation is organized and unified.

Clarity

Treatment matched to your actual risk, not overtreatment

Not every diagnosis means immediate surgery — active surveillance is a real option for low-risk cases.

Treatment Options by Risk Level

How Is Prostate Cancer Treated?

For Low-Risk Cases

Active Surveillance

Precise, periodic follow-up with PSA testing, imaging, and sometimes repeat biopsies, without immediate treatment. A genuine, carefully considered option for slow-growing tumors, not just a delay.

The Standard Surgical Option

Surgical Removal of the Prostate

Complete removal of the prostate gland, for confined cases requiring active intervention. Its potential impact on sexual function and urinary control is discussed with you openly before the decision.

Alternative or Complement by Stage

Radiation or Hormone Therapy

Targeted radiation therapy as an alternative to surgery in certain cases, with the possibility of adding hormone therapy for higher-risk or more advanced cases, coordinated with an oncologist when needed.

What Your Evaluation with Dr. Yaman Includes

A Complete Evaluation Protocol, Not a Surface-Level Exam

Diagnosis & Evaluation Pathway

One organized visit, personally overseen by Dr. Yaman

Review of family history and risk factors

To determine whether you need to start regular screening earlier than the usual age.

PSA test and digital exam

The first step in any evaluation, whether a routine visit or follow-up on a previously elevated result.

Multiparametric MRI when needed

Precisely identifies areas of suspicion before any decision on a biopsy.

Precisely targeted biopsy if needed

To confirm the diagnosis and determine the tumor’s grade and potential aggressiveness.

A written treatment plan matched to your actual risk level

Explained to you personally by Dr. Yaman, including the option of active surveillance if it fits your case.

No multiple referrals, no waiting between specialties — the entire pathway is under the care of one physician.

Signs Worth Paying Attention To

Symptoms of Prostate Cancer

Early cases often have no symptoms at all — which is exactly why regular screening matters. When symptoms do appear, they may include:

Clear difficulty or weakness in the urinary stream
Blood in the urine or semen
Erectile dysfunction with no other clear cause
Bone pain (in more advanced cases)
Unexplained weight loss
Persistent, unexplained fatigue

Medical Background

Risk Factors for Prostate Cancer

Advancing Age

The risk factor most strongly linked to the disease — the rate rises clearly after age fifty.

Family History

A father or brother with prostate cancer notably raises the risk, and calls for starting screening earlier.

Genetic Mutations

Certain known genetic mutations are linked to higher risk in some families.

Obesity and Diet

A diet high in fat and low in vegetables and fruit, along with obesity, are linked to higher risk.

Full
Clarity

Dr. Yaman’s Commitment to You

We don’t promise a specific medical outcome — that would be unethical and unrealistic in oncology. But here’s what we genuinely commit to: never suggesting treatment more aggressive than your actual case requires. If active surveillance is the medically appropriate option, that’s what will be presented to you honestly, not surgery simply because it seems like the “certain” choice on the surface.

Book Your Evaluation Now

Reach Dr. Yaman Al Tall’s team on WhatsApp — with complete privacy, and priority for cases needing a prompt evaluation.

Message Us on WhatsApp Now

Frequently Asked Questions

Everything You Need to Know About Prostate Cancer

No, they are two completely different conditions, even though both affect the same gland. Benign prostatic hyperplasia is very common with aging, is not cancer, and does not turn into it, while prostate cancer is a separate condition requiring its own diagnosis and evaluation — the two can exist together in the same patient with no causal relationship between them.

It depends heavily on the tumor’s stage and grade at diagnosis. Cases confined to the prostate and caught early through periodic screening are often treated with excellent results, which is exactly why regular PSA testing after a certain age matters.

No. Low-risk, slow-growing cases may be candidates for active surveillance instead of immediate intervention — a genuine, carefully considered option, not just a delay. The decision depends on the tumor’s grade and stage, the patient’s age, and overall health.

No, an elevated PSA calls for further evaluation and is not a confirmed diagnosis on its own, because causes other than cancer — such as benign prostatic hyperplasia or infection — can also raise it. A confirmed diagnosis usually requires an MRI and a precisely targeted biopsy.

It’s possible, and this is discussed openly before the surgery, not after. Modern techniques aim to minimize this impact as much as possible, but no absolute guarantee can be given, and it depends on each patient’s condition and the precise location of the tumor.

It’s generally advisable to start discussing PSA testing with a urologist around age fifty, or earlier if there is a family history or additional risk factors.